Skip to content
777 Sourcing.

Capability

CMC development

Suppliers
2
States & provinces
2
Countries
1

2 cmc development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Aspira Therapeutics is developing Aspirvent, a first-in-class alginate-based intragastric barrier device that forms a coherent gel raft on the gastric surface to physically prevent pulmonary aspiration during anesthesia induction and sedation. The company is prioritizing patients on GLP-1 therapy before expanding into broader pre-operative gastric-content protection.

alginate gel-raft formulationGMP-grade formulation manufacturingmedical device development

IMMUNOCORE COMMERCIAL LLC

CONSHOHOCKEN, PA

Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world's first approved T cell receptor (TCR) therapy. Built on its proprietary ImmTAX platform, it develops bispecific therapies for cancer, infectious diseases, and autoimmune diseases, including multiple cancers, HIV and HBV.

biomanufacturingbispecific therapy developmentclinical developmentT cell receptor (TCR) therapy discovery and development

Related capabilities

Other processes offered by the shops that list CMC development.

Browse all capabilities